Search

everythinglearnresearchcommunity

for

Search:↓

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

A woman developed a severe skin reaction after getting a birth control implant.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Pediatricians should advise sexually active teens on safe sex and STD prevention, and discuss contraceptive options and their side effects.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.